Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout

Educational Sessions

Intensive Studies for Recertification

The Aspirin Revolution Continues: Evaluating the Risks and Benefits of Aspirin Across the Spectrum of Cardiovascular Disease

Sunday, December 8, 2024
12:00 PM – 1:30 PM  
Location: MCCNO, Ballroom C, Level 2
CE Credits: 1.50 contact hours
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-24-237-L01-P
Activity Type: Application-based
Target Audience: Pharmacist, Board-Certified Pharmacist
NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board-certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

Aspirin remains one of the most commonly used medications in patients with cardiovascular (CV) disease; however, evidence for aspirin use across the spectrum of CV disease remains quite nuanced. This interactive session will critically evaluate the current literature while using a series of interactive patient case studies. The session will have structured pauses to propose case-based questions and group discussions, allowing attendees to determine the most appropriate role for aspirin therapy across the spectrum of CV disease. In the end, the audience will walk away with key take home points they can apply to their practice immediately.

This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.

Learning Objectives:

  • Evaluate the role of aspirin in patients with transient ischemic attack and stroke.
  • Discuss the role of aspirin in patients with peripheral arterial disease.
  • Recommend an antithrombotic therapy regimen optimizing bleeding and thrombosis prevention in patients with chronic coronary disease.